Drug Shortage Report for PROLENSA
Report ID | 175206 |
Drug Identification Number | 02439123 |
Brand name | PROLENSA |
Common or Proper name | Prolensa |
Company Name | BAUSCH & LOMB INC |
Market Status | MARKETED |
Active Ingredient(s) | BROMFENAC |
Strength(s) | 0.07% |
Dosage form(s) | SOLUTION |
Route of administration | OPHTHALMIC OPHTHALMIC |
Packaging size | Bottle |
ATC code | S01BC |
ATC description | ANTIINFLAMMATORY AGENTS |
Reason for shortage | Shortage of an active ingredient. |
Anticipated start date | 2022-11-14 |
Actual start date | 2022-11-14 |
Estimated end date | 2023-01-13 |
Actual end date | 2023-01-11 |
Shortage status | Resolved |
Updated date | 2023-01-16 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1400 N GOODMAN STREET ROCHESTER, NEW YORK UNITED STATES 14609 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2023-01-16 | French | Compare |
v3 | 2023-01-16 | English | Compare |
v2 | 2022-11-17 | French | Compare |
v1 | 2022-11-17 | English | Compare |
Showing 1 to 4 of 4